You can buy or sell Charles River and other stocks, options, ETFs, and crypto commission-free!
Charles River Laboratories International, Inc., also called Charles River, is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. Read More The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 20
Edited Transcript of CRL earnings conference call or presentation 7-May-19 12:30pm GMT
Q1 2019 Charles River Laboratories International Inc Earnings Call Wilmington May 13, 2019 (Thomson StreetEvents) -- Edited Transcript of Charles River Laboratories International Inc earnings conference call or presentation Tuesday, May 7, 2019 at 12:30:00pm GMT TEXT version of Transcript Scroll to continue with content Ad ================================================================================ Corporate Participants =============================================================================...
Yahoo FinanceMay 13
How Do Analysts See Charles River Laboratories International, Inc. Performing Over The Next Year?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! On 30 March 2019, Charles River Laboratories International, Inc. (NYSE:CRL) released its earnings update. Generally, analyst consensus outlook appear cautiously optimistic, with earnings expected to grow by 14% in the upcoming year against the past 5-year average growth rate of 8.7%. Currently with trailing-twelve-month earnings of US$225m, we can expect this to reach US$257m by 2020....
Expected Aug 7, Pre-Market